Source · Select Committees · Public Accounts Committee
Recommendation 30
30
The week before the start of the new financial year, the Department had still not...
Conclusion
The week before the start of the new financial year, the Department had still not finalised the allocation of its £9.6 billion Spending Review settlement for COVID-19 response activities, creating uncertainty for the vaccine programme. In the 2021 Spending Review, the Department received £9.6 billion for all its key COVID-19 programmes over the three years from 2022–23 to 2024–25.74 When we took evidence on 28 March, the Department still could not tell us how it would distribute this funding among its various programmes for 2022–23. This included the vaccine programme.75 It also had not finalised the 2022–23 budget for UKHSA, which has a key role in COVID-19 vaccine storage and distribution, and additionally supports the programme through its monitoring and analysis of vaccine coverage and effectiveness.76
Government Response
A response document is linked to this report, dated 8 November 2022. Response attribution to this conclusion has not been verified. Read the response document ↗